Translating the Biology of Aging into New Therapeutics for Alzheimer’s Disease: Senolytics
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Translating the Biology of Aging into New Therapeutics for Alzheimer’s Disease: Senolytics ; volume:10 ; number:4 ; day:24 ; month:10 ; year:2023 ; pages:633-646 ; date:11.2023
The journal of prevention of Alzheimer's disease ; 10, Heft 4 (24.10.2023), 633-646, 11.2023
- Urheber
-
Riessland, M.
Orr, Miranda E.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.14283/jpad.2023.104
- URN
-
urn:nbn:de:101:1-2024011208523556554252
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Riessland, M.
- Orr, Miranda E.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics
Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease
Next-generation Alzheimer’s Therapeutics: Leveraging Deep Biology
Recent developments in Alzheimer's disease therapeutics
Next generation therapeutics for Alzheimer's disease
Peripheral immune system in aging and Alzheimer’s disease
Mitochondrial links between brain aging and Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Blood–brain-barriers in aging and in Alzheimer’s disease
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Dysregulated gene-associated biomarkers for Alzheimer’s disease and aging
Myelin repair in Alzheimer’s disease: a review of biological pathways and potential therapeutics
Chemical entity normalization for successful translational development of Alzheimer’s disease and dementia therapeutics